NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
March 31, 2026 — Dr. Jake Dorfman offers braces and Invisalign in Bensalem, PA, with personalized orthodontic care for all ages. Learn about treatment options and community-focused services at Dorfman Orthodontic Group.
March 31, 2026 — Dr. Jake Dorfman offers braces and Invisalign in Southampton, PA, with personalized orthodontic care for all ages. Learn how his patient-first approach transforms smiles and boosts confidence.
March 31, 2026 — Rawle Orthodontics in Altamonte Springs provides clear aligners for kids, teens, and adults. Discover modern, discreet orthodontic treatment with advanced technology.
March 31, 2026 — Atlanta lice experts report rising school outbreaks due to pesticide-resistant super lice and stigma. Learn about chemical-free treatment options and prevention strategies for Georgia families.
March 31, 2026 — LIXTE Biotechnology's LB-100 is the world's first clinical-stage PP2A inhibitor, enhancing cancer therapy effectiveness. Learn how this innovation targets treatment resistance.
March 31, 2026 — Telomir Pharmaceuticals submits FDA IND for Telomir-1 targeting triple-negative breast cancer. Preclinical data shows tumor reduction and safety. Phase 1/2 trial pending clearance.
March 31, 2026 — Scientists discover androgens drive deadly pediatric brain cancer PFA ependymoma, with CNS Pharmaceuticals involved in treatment development. BioMedWire reports.
March 31, 2026 — Annovis Bio announces publication in The Scientist detailing buntanetap development for Alzheimer's and Parkinson's disease, with Phase 3 trials showing strong enrollment progress toward potential breakthrough treatment.
March 31, 2026 — Soligenix's SGX945 receives UK Promising Innovative Medicine designation, strengthening its rare disease pipeline and building on FDA orphan drug status for Behçet's disease treatment development.
March 31, 2026 — Tonix Pharmaceuticals announces positive Phase 1 data for TNX-4800, a long-acting monoclonal antibody for Lyme disease prevention showing 4-month protection in healthy subjects.
March 31, 2026 — Soligenix reports 2025 results, advancing HyBryte™ Phase 3 trial for CTCL and orphan drug designation for Behçet's Disease. Explore rare disease pipeline progress and public health vaccine developments.
March 31, 2026 — Nutriband selects brand name for its abuse-deterrent fentanyl patch using AVERSA™ tech, targeting an $80M-$200M U.S. market to enhance pain management safety.
March 31, 2026 — Lantern Pharma (LTRN) reports 2025 operational highlights: progress in Phase 2 LP-300 trial, FDA discussions set for 2026, and AI platform targets $15B+ oncology market.
March 31, 2026 — Cardio Diagnostics uses AI, epigenetics & genetics to detect heart disease via blood test. Non-invasive, no fasting needed. CMS reimbursement secured, expanding globally.
March 31, 2026 — Ocumetics Technology announces breakthrough accommodating intraocular lens design with German engineering collaboration. Enhanced performance, reliability & accelerated commercialization path for vision restoration technology.
March 31, 2026 — ioTech International leads the shift to oral care as preventive healthcare, using molecular iodine rinses to fight bacteria linked to heart disease and diabetes based on new scientific evidence.
March 31, 2026 — American Shared Hospital Services announces 2025 financial results, 7-year proton therapy lease extension with Orlando Health, and strategic expansion in direct patient care cancer treatment services.
March 31, 2026 — American Heart Association releases 2026 dietary guidance with 9 key features for heart-healthy eating patterns to reduce cardiovascular disease risk and improve lifelong health outcomes.
March 31, 2026 — Vivid Orthodontics offers Invisalign clear aligners in Appleton, WI for discreet smile straightening. Learn about benefits like invisibility, comfort, and flexible plans for all ages.
March 31, 2026 — BioXgen launches community investment for cardiac patch to prevent post-operative atrial fibrillation after open-heart surgery. FDA 510(k) pathway targeted with 10x reduction in complication rates.